Triple assessment with lipoprotein(a), high-sensitivity C-reactive protein and lipid profile stratified risk of major adverse cardiovascular events: 20-year follow-up of the Hong Kong Cardiovascular Risk Factor Prevalence Study (CRISPS)
The Lancet Regional Health - Western Pacific · 2026-11 · 76 · 102026
DOI: 10.1016/j.lanwpc.2026.102026 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Lancet Regional Health - Western Pacific, 2026-11. Verfasst von David T.W. Lui und 12 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Health and Medical Research Fund, University Grants Committee Research Grants Council.
Abstract (Originalsprache)
Background
We evaluated the association between the three biomarkers—routine lipid profile, high-sensitivity CRP (hsCRP) and lipoprotein(a)—and incident major adverse cardiovascular events (MACE) in an Asian cohort.
Methods
This analysis included community-dwelling Hong Kong Chinese individuals recruited in 2000–2004 who had concomitant measurements of lipoprotein(a), hsCRP and lipid profile. Participants were followed up from the measurement to MACE, death or 31 December 2024, whichever earlier. MACE was a composite of myocardial infarction, stroke and cardiovascular mortality. Multivariable Cox regression analysis was used to identify independent association of lipoprotein(a), hsCRP and lipid profile parameters with incident MACE, with model selection using LASSO. Associations between increasing number of abnormal biomarkers at baseline with incident MACE were examined.
Findings
1282 participants without prior MACE were included. Upon median follow-up of 19.6 years, 209 participants experienced MACE (incidence: 8.33 per 1000 person-years). Low HDL-cholesterol (adjusted HR [aHR] = 1.55, 95% CI 1.13–2.12, p = 0.006), hsCRP ≥ 2.0 mg/L (aHR = 1.83, 95% CI 1.30–2.56, p = 0.001) and lipoprotein(a) ≥50 mg/dL (aHR = 1.49, 95% CI 1.01–2.19, p = 0.042) independently predicted incident MACE, in addition to age, hypertension, diabetes, and history of cardiovascular disease. Increasing number of abnormal biomarker levels (low HDL-cholesterol, hsCRP ≥ 2.0 mg/L and lipoprotein(a) ≥50 mg/dL) was associated with increasing risk of incident MACE (1 abnormality, aHR 1.63 [95% CI 1.19–2.22, p = 0.023]; 2 abnormalities: aHR 2.75 [95% CI 1.76–4.28, p < 0.001]; 3 abnormalities: aHR 3.70 [95% CI 1.32–10.3, p = 0.013]).
Interpretation
In an Asian community-based cohort with 20-year follow-up, simultaneous measurements of lipid profile, hsCRP and lipoprotein(a) offered additional cardiovascular risk stratification, supporting the value of measuring hsCRP and lipoprotein(a) in addition to routine lipid profile in clinical practice. Funding: Health and Medical Research Fund (HSRF 1994 awarded to EJ; HMRF/HSRF 1997, 2000, 2008 awarded to KSLL); Research Grants Council (GRF 7290/97M, 7426/03M, 7404/04M, 7609/05M, 7590/06M, 7626/07M, 7672/08M, 7694/10M awarded to KSLL; GRF 7229/01M awarded to BMYC; CRF HKU3/CRF/9 and HKU2/CRF/12R awarded to KSLL; AoE/M-707/18 awarded to AX; Theme-based research T12/705/17 awarded to HFT).
Förderung
- Health and Medical Research Fund
- University Grants Committee Research Grants Council
Zitieren
APA
Lui, D. T., Wong, K. H., Fong, C. H., Janus, E., Xu, A., Tse, H., Cheung, B. M., Wat, N. M., Tso, A. W., Woo, Y., Tan, K. C., Lee, C., & Lam, K. S. (2026). Triple assessment with lipoprotein(a), high-sensitivity C-reactive protein and lipid profile stratified risk of major adverse cardiovascular events: 20-year follow-up of the Hong Kong Cardiovascular Risk Factor Prevalence Study (CRISPS). The Lancet Regional Health - Western Pacific, 76, 102026. https://doi.org/10.1016/j.lanwpc.2026.102026
Vancouver
Lui DT, Wong KH, Fong CH, Janus E, Xu A, Tse H, et al. Triple assessment with lipoprotein(a), high-sensitivity C-reactive protein and lipid profile stratified risk of major adverse cardiovascular events: 20-year follow-up of the Hong Kong Cardiovascular Risk Factor Prevalence Study (CRISPS). The Lancet Regional Health - Western Pacific. 2026;76:102026. doi:10.1016/j.lanwpc.2026.102026
BibTeX
@article{Lui2026,
author = {Lui, David T.W. and Wong, Kelly H.C. and Fong, Carol H.Y. and Janus, Edward and Xu, Aimin and Tse, Hung-Fat and Cheung, Bernard M.Y. and Wat, Nelson M.S. and Tso, Annette W.K. and Woo, Yu-Cho and Tan, Kathryn C.B. and Lee, Chi-Ho and Lam, Karen S.L.},
title = {Triple assessment with lipoprotein(a), high-sensitivity C-reactive protein and lipid profile stratified risk of major adverse cardiovascular events: 20-year follow-up of the Hong Kong Cardiovascular Risk Factor Prevalence Study (CRISPS)},
journal = {The Lancet Regional Health - Western Pacific},
year = {2026},
volume = {76},
pages = {102026},
doi = {10.1016/j.lanwpc.2026.102026}
}
EUVIMED